4-week Seaweed Supplementation on Menopause Symptoms and Psychological Wellbeing
Launched by NORTHUMBRIA UNIVERSITY · Mar 7, 2023
Trial Information
Current as of October 01, 2025
Completed
Keywords
ClinConnect Summary
Menopause and peri-menopause are associated with a number of symptoms and psychological well-being. Previous literature has found a relationship between diet and menopause management. For example, following the Mediterranean diet consuming a variety of vegetables, fruits, legumes and whole grains has found to improve menopausal symptoms particularly vasomotor symptoms. Few studies have explored the effects of dietary supplements on psychological well-being in menopause. The aim of the study is to explore the impact of an iodine-rich seaweed food supplement on menopause symptoms and mental w...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Self-assess as healthy
- • Experienced menopausal or peri-menopausal symptoms in the past 6 months
- Exclusion Criteria:
- • Are currently taking HRT, anti-depressants, or anti-anxiety medication
- • Are lactating or pregnant (or seeking to become pregnant)
- • Have a thyroid disorder
- • Are currently taking iodine supplements
- • Have any relevant food intolerances
About Northumbria University
Northumbria University is a leading research-intensive institution based in the UK, dedicated to advancing knowledge and innovation in various fields, including health sciences. As a clinical trial sponsor, the university leverages its academic expertise and state-of-the-art facilities to conduct high-quality research aimed at improving patient outcomes and informing clinical practices. With a commitment to ethical standards and regulatory compliance, Northumbria University collaborates with healthcare professionals and industry partners to explore novel therapeutic interventions and contribute to the body of evidence that shapes modern medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Newcastle Upon Tyne, United Kingdom
Patients applied
Trial Officials
Crystal Haskell-Ramsay
Principal Investigator
Northumbria University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials